TrialCardiovascular diabetology2024

Effect of empagliflozin on total myocardial infarction events by type and additional coronary outcomes: insights from the randomized EMPA-REG OUTCOME trial.

David Fitchett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.